Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
111studies shown
Showing 73-84 of 111
Drug study icon
CompletedNCT03345342

Paliperidone Palmitate 6-Month Formulation

This study is completed in the United States, in Australia, in France, .... It focuses on Schizophrenia.

In Australia
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
United States, Australia, France, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This study is completed. It focuses on bipolarity and currently lists study information in Australia, India, and the United States.

In Australia
Bipolarity, DepressionDrugOver 18 Years
Countries
United States, Australia, India
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Depression
Other study type icon
Active Not RecruitingNCT05905003

AMP SCZ® Observational Study: PREDICT-DPACC

This study is active but not recruiting. It focuses on schizophrenia and currently lists study information in Australia, Canada, Chile, China, Denmark, Germany, Italy, Singapore, South Korea, Spain, Switzerland, the United Kingdom, and the United States.

In Australia
SchizophreniaOtherFrom 12 Years to 30 Years
Countries
United States, Australia, Canada, ...
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia
Drug study icon
WithdrawnNCT05357040

Antidepressant Effects of Nitrous Oxide

This study has public registry information. It focuses on depression and currently lists study information in Australia and the United States.

In Australia
DepressionDrugOver 18 Years
Countries
United States, Australia
Sponsor
University of Chicago
Condition
Depression
Drug study icon
CompletedNCT01358357

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This study is completed. It focuses on bipolarity and currently lists study information in Argentina, Australia, Bulgaria, Chile, Croatia, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, and the United States.

In Australia
BipolarityDrugOver 18 Years
Countries
United States, Australia, France, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT04846868

study of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

This study is completed. It focuses on schizophrenia and currently lists study information in Australia, Brazil, Canada, China, Colombia, Germany, Greece, Italy, Japan, Mexico, New Zealand, Norway, the Philippines, Poland, Sweden, Turkey, and the United States.

In Australia
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Australia, Canada, ...
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia